Brief: Truveta And Alpine Immune Sciences Announce Strategic Partnership To Access Truveta’S Community To Accelerate Recruitment To Povetacicept Clinical Trials
22/03/2023 12:55
March 22 (Reuters) - Alpine Immune Sciences Inc
ALPN.O :
* TRUVETA AND ALPINE IMMUNE SCIENCES ANNOUNCE STRATEGIC
PARTNERSHIP TO ACCESS TRUVETA’S COMMUNITY TO ACCELERATE
RECRUITMENT TO POVETACICEPT CLINICAL TRIALS
Source text for Eikon: ID:nGNX8QQdsY
Further company coverage: ALPN.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Alpine Immune Sciences
See all newsAlpine Immune Sciences Inc reports results for the quarter ended in January - Earnings Summary
Brief: Alpine Immune Sciences Q1 EPS USD -0.28 Vs. IBES Estimate USD -0.41
Moves: Lazard hires veteran healthcare dealmaker Colocci as vice chairman
U.S. RESEARCH ROUNDUP-Cheesecake Factory, Netflix, Texas Roadhouse
US STOCKS-S&P 500, Nasdaq end sharply higher on soft inflation data, eyes on earnings